‘People Don’t Live in Siloes’: Appeal for HIV Services to Include Mental Health and Other Chronic Diseases 31/07/2022 Kerry Cullinan MONTREAL – People with mental health conditions are more likely to get HIV, while people with HIV often struggle with depression and other mental health issues – but few countries offer psychosocial support as part of their HIV services. “As a result of systemic inequalities, mental health issues keep coming up and you have to […] Continue reading -> UNAIDS: COVID-19 and Plummeting Donor Funds Slow Progress Against HIV 28/07/2022 Kerry Cullinan MONTREAL – Progress against HIV has slowed down during the COVID-19 pandemic as donors pull back, countries test and treat fewer people and miss key targets, UNAIDS revealed on Wednesday. “Progress in prevention and treatment is faltering around the world, putting millions of people in grave danger. Eastern Europe and central Asia, Latin America, and […] Continue reading -> After Battling AIDS and Cancer, Kwenda Champions Integrated NCDs & HIV Patient Care 27/07/2022 Kerry Cullinan Sally Agallo Kwenda’s first baby only lived for two days. She fell pregnant again almost immediately but her second son was born prematurely and died soon afterwards. Shortly after his death, she learnt that she had AIDS. Some years later, after struggling with depression and grief, Kwenda was diagnosed with stage two cervical cancer – […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Migrants and Refugees Face Big Hurdles to Access Health Services in Two-Thirds of Host Countries: Landmark WHO Report 20/07/2022 Elaine Ruth Fletcher Dr Waheed Araian spent the first five years of his life hiding with his family in a cellar in Kabul from rockets and bombs. “I came to the UK as a 15-year-old child refugee with no family support, hardly any education and about $100 in my pocket,” said Arian, now an emergency doctor in the […] Continue reading -> Zero Alcohol Recommendation for People Under 40 15/07/2022 Kerry Cullinan Alcohol has no benefits for people under the age of 40, but drinking a small amount of alcohol by healthy people over 40 might have some health benefits, according to a study conducted by the Global Burden of Disease study, published in The Lancet on Friday. The study – the first to report alcohol risk […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
UNAIDS: COVID-19 and Plummeting Donor Funds Slow Progress Against HIV 28/07/2022 Kerry Cullinan MONTREAL – Progress against HIV has slowed down during the COVID-19 pandemic as donors pull back, countries test and treat fewer people and miss key targets, UNAIDS revealed on Wednesday. “Progress in prevention and treatment is faltering around the world, putting millions of people in grave danger. Eastern Europe and central Asia, Latin America, and […] Continue reading -> After Battling AIDS and Cancer, Kwenda Champions Integrated NCDs & HIV Patient Care 27/07/2022 Kerry Cullinan Sally Agallo Kwenda’s first baby only lived for two days. She fell pregnant again almost immediately but her second son was born prematurely and died soon afterwards. Shortly after his death, she learnt that she had AIDS. Some years later, after struggling with depression and grief, Kwenda was diagnosed with stage two cervical cancer – […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Migrants and Refugees Face Big Hurdles to Access Health Services in Two-Thirds of Host Countries: Landmark WHO Report 20/07/2022 Elaine Ruth Fletcher Dr Waheed Araian spent the first five years of his life hiding with his family in a cellar in Kabul from rockets and bombs. “I came to the UK as a 15-year-old child refugee with no family support, hardly any education and about $100 in my pocket,” said Arian, now an emergency doctor in the […] Continue reading -> Zero Alcohol Recommendation for People Under 40 15/07/2022 Kerry Cullinan Alcohol has no benefits for people under the age of 40, but drinking a small amount of alcohol by healthy people over 40 might have some health benefits, according to a study conducted by the Global Burden of Disease study, published in The Lancet on Friday. The study – the first to report alcohol risk […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
After Battling AIDS and Cancer, Kwenda Champions Integrated NCDs & HIV Patient Care 27/07/2022 Kerry Cullinan Sally Agallo Kwenda’s first baby only lived for two days. She fell pregnant again almost immediately but her second son was born prematurely and died soon afterwards. Shortly after his death, she learnt that she had AIDS. Some years later, after struggling with depression and grief, Kwenda was diagnosed with stage two cervical cancer – […] Continue reading -> Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Migrants and Refugees Face Big Hurdles to Access Health Services in Two-Thirds of Host Countries: Landmark WHO Report 20/07/2022 Elaine Ruth Fletcher Dr Waheed Araian spent the first five years of his life hiding with his family in a cellar in Kabul from rockets and bombs. “I came to the UK as a 15-year-old child refugee with no family support, hardly any education and about $100 in my pocket,” said Arian, now an emergency doctor in the […] Continue reading -> Zero Alcohol Recommendation for People Under 40 15/07/2022 Kerry Cullinan Alcohol has no benefits for people under the age of 40, but drinking a small amount of alcohol by healthy people over 40 might have some health benefits, according to a study conducted by the Global Burden of Disease study, published in The Lancet on Friday. The study – the first to report alcohol risk […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
Thanks to COVID-19, Alarm Grows Over Drug Resistant Infections 26/07/2022 Catherine Davison, via The New Humanitarian (DELHI, India via The New Humanitarian) – As medical professionals across the globe grappled with COVID-19 infections, microbiologist Dr. Bhavani Eshwaragari was confronting a quieter – though no less dangerous – pandemic. Reviewing patient samples in her laboratory in Continental Hospital in the southern India city of Hyderabad, she began to notice an alarming trend […] Continue reading -> Migrants and Refugees Face Big Hurdles to Access Health Services in Two-Thirds of Host Countries: Landmark WHO Report 20/07/2022 Elaine Ruth Fletcher Dr Waheed Araian spent the first five years of his life hiding with his family in a cellar in Kabul from rockets and bombs. “I came to the UK as a 15-year-old child refugee with no family support, hardly any education and about $100 in my pocket,” said Arian, now an emergency doctor in the […] Continue reading -> Zero Alcohol Recommendation for People Under 40 15/07/2022 Kerry Cullinan Alcohol has no benefits for people under the age of 40, but drinking a small amount of alcohol by healthy people over 40 might have some health benefits, according to a study conducted by the Global Burden of Disease study, published in The Lancet on Friday. The study – the first to report alcohol risk […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
Migrants and Refugees Face Big Hurdles to Access Health Services in Two-Thirds of Host Countries: Landmark WHO Report 20/07/2022 Elaine Ruth Fletcher Dr Waheed Araian spent the first five years of his life hiding with his family in a cellar in Kabul from rockets and bombs. “I came to the UK as a 15-year-old child refugee with no family support, hardly any education and about $100 in my pocket,” said Arian, now an emergency doctor in the […] Continue reading -> Zero Alcohol Recommendation for People Under 40 15/07/2022 Kerry Cullinan Alcohol has no benefits for people under the age of 40, but drinking a small amount of alcohol by healthy people over 40 might have some health benefits, according to a study conducted by the Global Burden of Disease study, published in The Lancet on Friday. The study – the first to report alcohol risk […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
Zero Alcohol Recommendation for People Under 40 15/07/2022 Kerry Cullinan Alcohol has no benefits for people under the age of 40, but drinking a small amount of alcohol by healthy people over 40 might have some health benefits, according to a study conducted by the Global Burden of Disease study, published in The Lancet on Friday. The study – the first to report alcohol risk […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
COVID-19 Support Steady Despite Global Partnership’s ‘Transition’ 06/07/2022 Kerry Cullinan Organizers say they have no plans to “sunset” the support they offer countries through the Access to COVID-19 Tools (ACT) Accelerator, the global partnership to facilitate equitable access to COVID-19 tests, treatments, and vaccines. The ACT-A, however, will undergo a “transition” when its strategic plan and budget ends in September, according to the World Health […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts
Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> Posts navigation Older postsNewer posts